Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$513K	Hold	40,000	–	–	0.26%	84
2025 Q4	$360K	Sell	40,000 -40,000	-50%	-$551K	0.18%	90
2025 Q3	$1.38M	Sell	80,000 -20,000	-20%	-$246K	0.73%	45
2025 Q2	$938K	Buy	100,000 +19,000	+23%	+$156K	0.49%	60
2025 Q1	$576K	Buy	81,000 +19,000	+31%	+$192K	0.37%	73
2024 Q4	$723K	Buy	62,000 +27,000	+77%	+$421K	0.42%	68
2024 Q3	$719K	Buy	35,000 +2,000	+6%	+$46.1K	0.46%	66
2024 Q2	$739K	Buy	33,000 +6,000	+22%	+$143K	0.48%	62
2024 Q1	$743K	Buy	27,000 +6,000	+29%	+$167K	0.51%	63
2023 Q4	$640K	Hold	21,000	–	–	0.53%	62
2023 Q3	$640K	Buy	21,000 +10,000	+91%	+$388K	0.53%	62
2023 Q2	$449K	Buy	11,000 +2,000	+22%	+$81.1K	0.39%	72
2023 Q1	$335K	Buy	+9,000	New	+$353K	0.35%	73